Transcriptional coregulators: Emerging roles of SRC family of coactivators in disease pathology

Journal of Molecular Endocrinology

Volumn 53, Issue 2, 2014, Pages R47-R59

  Dasgupta, Subhamoy ^a   O’malley, Bert W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Hormone receptors; Nuclear receptors; Transcription; Transcription factors

Indexed keywords

CASEIN KINASE; CELL NUCLEUS RECEPTOR; CYCLIN DEPENDENT KINASE 9; EPIDERMAL GROWTH FACTOR RECEPTOR; FOCAL ADHESION KINASE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; LYSINE; NUCLEAR RECEPTOR COACTIVATOR 2; REGULATOR PROTEIN; STEROID RECEPTOR COACTIVATOR; STEROID RECEPTOR COACTIVATOR 3; TRANSCRIPTION FACTOR; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; MULTIPROTEIN COMPLEX; PROTEIN BINDING;

BIOLOGICAL FUNCTIONS; BREAST CANCER; CANCER THERAPY; CIRCADIAN RHYTHM; CONFORMATIONAL TRANSITION; DEGENERATIVE DISEASE; ENDOMETRIUM CANCER; GENE EXPRESSION REGULATION; GENETIC DISORDER; GLYCOGEN STORAGE DISEASE TYPE 1; HEART DEVELOPMENT; HEART DISEASE; HUMAN; HUNTINGTON CHOREA; INFLAMMATORY DISEASE; METABOLIC DISORDER; NEOPLASM; NEUROLOGIC DISEASE; NONHUMAN; OVARY CANCER; PATHOLOGY; PATHOPHYSIOLOGY; PROSTATE CANCER; PROTEIN ACETYLATION; PROTEIN METHYLATION; PROTEIN PHOSPHORYLATION; PROTEOMICS; REVIEW; RUBINSTEIN SYNDROME; SIGNAL TRANSDUCTION; SUMOYLATION; TRANSCRIPTION REGULATION; UBIQUITINATION; ANIMAL; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PROTEIN PROCESSING; TRANSCRIPTION INITIATION;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; MULTIPROTEIN COMPLEXES; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 84907964856     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-14-0080     Document Type: Review

References (93)

1. Agoulnik IU & Weigel NL 2008 Androgen receptor coactivators and prostate cancer. Advances in Experimental Medicine and Biology 617 245-255. (doi:10.1007/978-0-387-69080-3_23)
2. Agoulnik IU, Vaid A, Nakka M, Alvarado M, Bingman WE III, Erdem H, Frolov A, Smith CL, Ayala GE, Ittmann MM et al. 2006 Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer. Cancer Research 66 10594-10602. (doi:10.1158/0008-5472.CAN-06-1023)
3. Allan GF, Leng X, Tsai SY, Weigel NL, Edwards DP, Tsai MJ & O’Malley BW 1992 Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. Journal of Biological Chemistry 267 19513-19520.
4. Arany Z, Foo SY, Ma Y, Ruas JL, Bommi-Reddy A, Girnun G, Cooper M, Laznik D, Chinsomboon J, Rangwala SM et al. 2008 HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1a. Nature 451 1008-1012. (doi:10.1038/nature06613)
5. Asher G & Schibler U 2011 Crosstalk between components of circadian and metabolic cycles in mammals. Cell Metabolism 13 125-137. (doi:10.1016/j.cmet.2011.01.006)
6. Baniahmad A, Ha I, Reinberg D, Tsai S, Tsai MJ & O’Malley BW 1993 Interaction of human thyroid hormone receptor beta with transcription factor TFIIB may mediate target gene derepression and activation by thyroid hormone. PNAS 90 8832-8836. (doi:10.1073/pnas.90. 19.8832)
7. Baniahmad A, Leng X, Burris TP, Tsai SY, Tsai MJ & O’Malley BW 1995a The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing. Molecular and Cellular Biology 15 76-86.
8. Baniahmad C, Nawaz Z, Baniahmad A, Gleeson MA, Tsai MJ & O’Malley BW 1995b Enhancement of human estrogen receptor activity by SPT6: a potential coactivator. Molecular Endocrinology 9 34-43.
9. Banke NH, Wende AR, Leone TC, O’Donnell JM, Abel ED, Kelly DP & Lewandowski ED 2010 Preferential oxidation of triacylglyceridederived fatty acids in heart is augmented by the nuclear receptor PPARa. Circulation Research 107 233-241. (doi:10.1161/CIRCRESAHA.110.221713)
10. Barnes PJ 2013 Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. Journal of Allergy and Clinical Immunology 131 636-645. (doi:10.1016/j.jaci.2012.12.1564)
11. Barnes PJ, Adcock IM & Ito K 2005 Histone acetylation and deacetylation: importance in inflammatory lung diseases. European Respiratory Journal 25 552-563. (doi:10.1183/09031936.05.00117504)
12. Cavailles V, Dauvois S, Danielian PS & Parker MG 1994 Interaction of proteins with transcriptionally active estrogen receptors. PNAS 91 10009-10013. (doi:10.1073/pnas.91.21.10009)
13. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E et al. 2012 The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discovery 2 401-404.
14. Chaturvedi RK, Adhihetty P, Shukla S, Hennessy T, Calingasan N, Yang L, Starkov A, Kiaei M, Cannella M, Sassone J et al. 2009 Impaired PGC-1a function in muscle in Huntington’s disease. Human Molecular Genetics 18 3048-3065. (doi:10.1093/hmg/ddp243)
15. Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, Privalsky ML, Nakatani Y & Evans RM 1997 Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90 569-580. (doi:10.1016/S0092-8674(00)80516-4)
16. Chen H, Lin RJ, Xie W, Wilpitz D & Evans RM 1999 Regulation of hormoneinduced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell 98 675-686. (doi:10.1016/S0092-8674(00)80054-9)
17. Chitilian JM, Thillainadesan G, Manias JL, Chang WY, Walker E, Isovic M, Stanford WL & Torchia J 2014 Critical components of the pluripotency network are targets for the p300/CBPinteracting protein (p/CIP) in embryonic stem cells. Stem Cells 32 204-215. (doi:10.1002/stem.1564)
18. Chopra AR, Louet JF, Saha P, An J, Demayo F, Xu J, York B, Karpen S, Finegold M, Moore D et al. 2008 Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke’s disease. Science 322 1395-1399. (doi:10.1126/science.1164847)
19. Chopra AR, Kommagani R, Saha P, Louet JF, Salazar C, Song J, Jeong J, Finegold M, Viollet B, DeMayo F et al. 2011 Cellular energy depletion resets whole-body energy by promoting coactivator-mediated dietary fuel absorption. CellMetabolism 13 35-43. (doi:10.1016/j.cmet.2010.12.001)
20. Cosio BG, Mann B, Ito K, Jazrawi E, Barnes PJ, Chung KF & Adcock IM 2004 Histone acetylase and deacetylase activity in alveolar macrophages and blood monocytes in asthma. American Journal of Respiratory and Critical Care Medicine 170 141-147. (doi:10.1164/rccm.200305-659OC)
21. Couture JF & Trievel RC 2006 Histone-modifying enzymes: encrypting an enigmatic epigenetic code. Current Opinion in Structural Biology 16 753-760. (doi:10.1016/j.sbi.2006.10.002)
22. Dasgupta S, Zhang B, Louet JF & O’Malley BW 2012a Steroid receptor coactivator-2 mediates oncogenic reprogramming of cancer cell metabolism. Cancer Research 72 Abstract nr 5153 (Proceedings: AACR 103rd Annual Meeting 2012, Mar 31-Apr 4, 2012; Chicago, IL, USA). (doi:10.1158/1538-7445.AM2012-5153)
23. Dasgupta S, Srinidhi S & Vishwanatha JK 2012b Oncogenic activation in prostate cancer progression and metastasis: molecular insights and future challenges. Journal of Carcinogenesis 11 4. (doi:10.4103/1477-3163.93001)
24. Dasgupta S, Lonard DM & O’Malley BW 2014 Nuclear receptor coactivators: master regulators of human health and disease. Annual Review of Medicine 65 279-292. (doi:10.1146/annurev-med-051812-145316)
25. Denner LA, Weigel NL, Maxwell BL, Schrader WT & O’Malley BW 1990 Regulation of progesterone receptor-mediated transcription by phosphorylation. Science 250 1740-1743. (doi:10.1126/science.2176746)
26. Dobrovolna J, Chinenov Y, Kennedy MA, Liu B & Rogatsky I 2012 Glucocorticoid-dependent phosphorylation of the transcriptional coregulator GRIP1. Molecular and Cellular Biology 32 730-739. (doi:10.1128/MCB.06473-11)
27. Eisen JA, Sweder KS & Hanawalt PC 1995 Evolution of the SNF2 family of proteins: subfamilies with distinct sequences and functions. Nucleic Acids Research 23 2715-2723. (doi:10.1093/nar/23.14.2715)
28. Feng Q, Yi P, Wong J & O’Malley BW 2006 Signaling within a coactivator complex: methylation of SRC-3/AIB1 is a molecular switch for complex disassembly. Molecular and Cellular Biology 26 7846-7857. (doi:10.1128/MCB.00568-06)
29. Ferry C, Gaouar S, Fischer B, Boeglin M, Paul N, Samarut E, Piskunov A, Pankotai-Bodo G, Brino L & Rochette-Egly C 2011 Cullin 3 mediates SRC-3 ubiquitination and degradation to control the retinoic acid response. PNAS 108 20603-20608. (doi:10.1073/pnas.1102572108)
30. Foulds CE, Feng Q, Ding C, Bailey S, Hunsaker TL, Malovannaya A, Hamilton RA, Gates LA, Zhang Z, Li C et al. 2013 Proteomic analysis of coregulators bound to ERa on DNA and nucleosomes reveals coregulator dynamics. Molecular Cell 51 185-199. (doi:10.1016/j.molcel.2013.06.007)
31. Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E et al. 2013 Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signaling 6 (269) pl1. (doi:10.1126/scisignal.2004088)
32. Geng C, He B, Xu L, Barbieri CE, Eedunuri VK, Chew SA, Zimmermann M, Bond R, Shou J, Li C et al. 2013 Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover. PNAS 110 6997-7002. (doi:10.1073/pnas. 1304502110)
33. Gibbons RJ, Brueton L, Buckle VJ, Burn J, Clayton-Smith J, Davison BC, Gardner RJ, Homfray T, Kearney L & Kingston HM 1995 Clinical and hematologic aspects of the X-linked a-thalassemia/mental retardation syndrome (ATR-X). American Journal of Medical Genetics 55 288-299. (doi:10.1002/ajmg.1320550309)
34. Gibbons RJ, Wada T, Fisher CA, Malik N, Mitson MJ, Steensma DP, Fryer A, Goudie DR, Krantz ID & Traeger-Synodinos J 2008 Mutations in the chromatin-associated protein ATRX. Human Mutation 29 796-802. (doi:10.1002/humu.20734)
35. Gregory CW, Fei X, Ponguta LA, He B, Bill HM, French FS & Wilson EM 2004 Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer. Journal of Biological Chemistry 279 7119-7130. (doi:10.1074/jbc.M307649200)
36. Halachmi S, Marden E, Martin G, MacKay H, Abbondanza C & Brown M 1994 Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264 1455-1458. (doi:10.1126/science.8197458)
37. Han SJ, Lonard DM & O’Malley BW 2009 Multi-modulation of nuclear receptor coactivators through posttranslational modifications. Trends in Endocrinology and Metabolism 20 8-15. (doi:10.1016/j.tem. 2008.10.001)
38. Han SJ, Hawkins SM, Begum K, Jung SY, Kovanci E, Qin J, Lydon JP, DeMayo FJ & O’Malley BW 2012 A new isoform of steroid receptor coactivator-1 is crucial for pathogenic progression of endometriosis. Nature Medicine 18 1102-1111. (doi:10.1038/nm.2826)
39. Hock MB & Kralli A 2009 Transcriptional control of mitochondrial biogenesis and function. Annual Review of Physiology 71 177-203. (doi:10.1146/annurev.physiol.010908.163119)
40. Lahue RS & Frizzell A 2012 Histone deacetylase complexes as caretakers of genome stability. Epigenetics 7 806-810. (doi:10.4161/epi.20922)
41. Lehman JJ, Barger PM, Kovacs A, Saffitz JE, Medeiros DM & Kelly DP 2000 Peroxisome proliferator-activated receptor g coactivator-1 promotes cardiac mitochondrial biogenesis. Journal of Clinical Investigation 106 847-856. (doi:10.1172/JCI10268)
42. Li C, Liang YY, Feng XH, Tsai SY, Tsai MJ & O’Malley BW 2008 Essential phosphatases and a phospho-degron are critical for regulation of SRC-3/AIB1 coactivator function and turnover. Molecular Cell 31 835-849. (doi:10.1016/j.molcel.2008.07.019)
43. Lonard DM & O’Malley BW 2007 Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation. Molecular Cell 27 691-700. (doi:10.1016/j.molcel.2007.08.012)
44. Lonard DM & O’Malley BW 2012 Nuclear receptor coregulators: modulators of pathology and therapeutic targets. Nature Reviews. Endocrinology 8 598-604. (doi:10.1038/nrendo.2012.100)
45. Long W, Yi P, Amazit L, LaMarca HL, Ashcroft F, Kumar R, Mancini MA, Tsai SY, Tsai MJ & O’Malley BW 2010 SRC-3D4mediates the interaction of EGFR with FAK to promote cell migration.Molecular Cell 37 321-332. (doi:10.1016/j.molcel.2010.01.004)
46. Long W, Foulds CE, Qin J, Liu J, Ding C, Lonard DM, Solis LM, Wistuba II, Qin J, Tsai SY et al. 2012 ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion. Journal of Clinical Investigation 122 1869-1880. (doi:10.1172/JCI61492)
47. Louet JF, Chopra AR, Sagen JV, An J, York B, Tannour-Louet M, Saha PK, Stevens RD, Wenner BR, Ilkayeva OR et al. 2010 The coactivator SRC-1 is an essential coordinator of hepatic glucose production. Cell Metabolism 12 606-618. (doi:10.1016/j.cmet.2010.11.009)
48. Malovannaya A, Li Y, Bulynko Y, Jung SY, Wang Y, Lanz RB, O’Malley BW & Qin J 2010 Streamlined analysis schema for high-throughput identification of endogenous protein complexes. PNAS 107 2431-2436. (doi:10.1073/pnas.0912599106)
49. Malovannaya A, Lanz RB, Jung SY, Bulynko Y, Le NT, Chan DW, Ding C, Shi Y, Yucer N, Krenciute G et al. 2011 Analysis of the human endogenous coregulator complexome. Cell 145 787-799. (doi:10.1016/j.cell.2011.05.006)
50. McBryan J, Theissen SM, Byrne C, Hughes E, Cocchiglia S, Sande S, O’Hara J, Tibbitts P, Hill AD & Young LS 2012 Metastatic progression with resistance to aromatase inhibitors is driven by the steroid receptor coactivator SRC-1. Cancer Research 72 548-559. (doi:10.1158/0008-5472. CAN-11-2073)
51. McDonnell DP, Nawaz Z & O’Malley BW 1991a In situ distinction between steroid receptor binding and transactivation at a target gene. Molecular and Cellular Biology 11 4350-4355.
52. McDonnell DP, Nawaz Z, Densmore C, Weigel NL, Pham TA, Clark JH & O’Malley BW 1991b High level expression of biologically active estrogen receptor in Saccharomyces cerevisiae. Journal of Steroid Biochemistry and Molecular Biology 39 291-297. (doi:10.1016/0960-0760(91)90038-7)
53. McDonnell DP, Vegeto E & O’Malley BW 1992 Identification of a negative regulatory function for steroid receptors. PNAS 89 10563-10567. (doi:10.1073/pnas.89.22.10563)
54. Means AR, Comstock JP, Rosenfeld GC & O’Malley BW 1972 Ovalbumin messenger RNA of chick oviduct: partial characterization, estrogen dependence, and translation in vitro. PNAS 69 1146-1150. (doi:10.1073/pnas.69.5.1146)
55. Meijer OC, Steenbergen PJ & De Kloet ER 2000 Differential expression and regional distribution of steroid receptor coactivators SRC-1 and SRC-2 in brain and pituitary. Endocrinology 141 2192-2199. (doi:10.1210/endo.141.6.7489)
56. Motamed M, Rajapakshe KI, Hartig SM, Coarfa C, Moses RE, Lonard DM & O’Malley BW 2014 Steroid receptor coactivator 1 is an integrator of glucose and NAD(C)/NADH homeostasis. Molecular Endocrinology 28 395-405. (doi:10.1210/me.2013-1404)
57. Onate SA, Tsai SY, Tsai MJ & O’Malley BW 1995 Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270 1354-1357. (doi:10.1126/science.270.5240.1354)
58. Park E, Kim Y, Ryu H, Kowall NW, Lee J & Ryu H 2014 Epigenetic mechanisms of Rubinstein-Taybi syndrome. Neuromolecular Medicine 16 16-24. (doi:10.1007/s12017-013-8285-3)
59. Percharde M, Lavial F, Ng JH, Kumar V, Tomaz RA, Martin N, Yeo JC, Gil J, Prabhakar S, Ng HH et al. 2012 Ncoa3 functions as an essential Esrrb coactivator to sustain embryonic stem cell self-renewal and reprogramming. Genes and Development 26 2286-2298. (doi:10.1101/gad. 195545.112)
60. Picard F, Gehin M, Annicotte J, Rocchi S, Champy MF, O’Malley BW, Chambon P & Auwerx J 2002 SRC-1 and TIF2 control energy balance between white and brown adipose tissues. Cell 111 931-941. (doi:10.1016/S0092-8674(02)01169-8)
61. Power RF, Mani SK, Codina J, Conneely OM & O’Malley BW 1991 Dopaminergic and ligand-independent activation of steroid hormone receptors. Science 254 1636-1639. (doi:10.1126/science.1749936)
62. Qin L, Liu Z, Chen H & Xu J 2009 The steroid receptor coactivator-1 regulates twist expression and promotes breast cancer metastasis. Cancer Research 69 3819-3827. (doi:10.1158/0008-5472.CAN-08-4389)
63. Qin L, Chen X, Wu Y, Feng Z, He T, Wang L, Liao L & Xu J 2011 Steroid receptor coactivator-1 upregulates integrin a(5) expression to promote breast cancer cell adhesion and migration. Cancer Research 71 1742-1751. (doi:10.1158/0008-5472.CAN-10-3453)
64. Qu Y, Yang Y, Ma D, He L & Xiao W 2013 Expression level of histone deacetylase 2 correlates with occurring of chronic obstructive pulmonary diseases. Molecular Biology Reports 40 3995-4000. (doi:10.1007/s11033-012-2477-z)
65. Reineke EL, York B, Stashi E, Chen X, Tsimelzon A, Xu J, Newgard CB, Taffet GE, Taegtmeyer H, Entman ML et al. 2012 SRC-2 coactivator deficiency decreases functional reserve in response to pressure overload of mouse heart. PLoS ONE 7 e53395. (doi:10.1371/journal.pone.0053395)
66. Reiter R, Wellstein A & Riegel AT 2001 An isoform of the coactivator AIB1 that increases hormone and growth factor sensitivity is overexpressed in breast cancer. Journal of Biological Chemistry 276 39736-39741. (doi:10.1074/jbc.M104744200)
67. Rowan BG, Garrison N, Weigel NL & O’Malley BW 2000 8-Bromo-cyclic AMP, induces phosphorylation of two sites in SRC-1 that facilitate ligand-independent activation of the chicken progesterone receptor and are critical for functional cooperation between SRC-1 and CREB binding protein. Molecular and Cellular Biology 20 8720-8730. (doi:10.1128/MCB.20.23.8720-8730.2000)
68. Rowe GC, Jiang A & Arany Z 2010 PGC-1 coactivators in cardiac development and disease. Circulation Research 107 825-838. (doi:10.1161/CIRCRESAHA.110.223818)
69. Spelsberg TC, Steggles AW & O’Malley BW 1971 Progesterone-binding components of chick oviduct. 3. chromatin acceptor sites. Journal of Biological Chemistry 246 4188-4197.
70. Stashi E, Wang L, Mani SK, York B & O’Malley BW 2013 Research resource: Loss of the steroid receptor coactivators confers neurobehavioral consequences. Molecular Endocrinology 27 1776-1787. (doi:10.1210/me.2013-1192)
71. Stashi E, Lanz RB, Mao J, Michailidis G, Zhu B, Kettner NM, Putluri N, Reineke EL, Reineke LC, Dasgupta S et al. 2014 SRC-2 is an essential coactivator for orchestrating metabolism and circadian rhythm. Cell Reports 6 633-645. (doi:10.1016/j.celrep.2014.01.027)
72. Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, Arora VK, Kaushik P, Cerami E, Reva B et al. 2010 Integrative genomic profiling of human prostate cancer. Cancer Cell 18 11-22. (doi:10.1016/j.ccr.2010.05.026)
73. Torchia J, Rose DW, Inostroza J, Kamei Y, Westin S, Glass CK & Rosenfeld MG 1997 The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387 677-684. (doi:10.1038/42652)
74. Urdinguio RG, Sanchez-Mut JV & Esteller M 2009 Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurology 8 1056-1072. (doi:10.1016/S1474-4422(09)70262-5)
75. Vazquez F, Lim JH, Chim H, Bhalla K, Girnun G, Pierce K, Clish CB, Granter SR, Widlund HR, Spiegelman BM et al. 2013 PGC1a expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress. Cancer Cell 23 287-301. (doi:10.1016/j.ccr.2012.11.020)
76. Vegeto E, Allan GF, Schrader WT, Tsai MJ, McDonnell DP & O’Malley BW 1992 The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor. Cell 69 703-713. (doi:10.1016/0092-8674(92)90234-4)
77. Voegel JJ, Heine MJ, Zechel C, Chambon P & Gronemeyer H 1996 TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO Journal 15 3667-3675.
78. Wang Y, Lonard DM, Yu Y, Chow DC, Palzkill TG, Wang J, Qi R, Matzuk AJ, Song X, Madoux F et al. 2014 Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1. Cancer Research 74 1506-1517. (doi:10.1158/0008-5472.CAN-13-2939)
79. Wu RC, Qin J, Yi P, Wong J, Tsai SY, Tsai MJ & O’Malley BW 2004 Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic responses to multiple cellular signaling pathways. Molecular Cell 15 937-949. (doi:10.1016/j.molcel.2004.08.019)
80. Wu H, Sun L, Zhang Y, Chen Y, Shi B, Li R, Wang Y, Liang J, Fan D, Wu G et al. 2006 Coordinated regulation of AIB1 transcriptional activity by sumoylation and phosphorylation. Journal of Biological Chemistry 281 21848-21856. (doi:10.1074/jbc.M603772200)
81. Wu RC, Feng Q, Lonard DM & O’Malley BW 2007 SRC-3 coactivator functional lifetime is regulated by a phospho-dependent ubiquitin time clock. Cell 129 1125-1140. (doi:10.1016/j.cell.2007.04.039)
82. Wu Z, Yang M, Liu H, Guo H, Wang Y, Cheng H & Chen L 2012 Roleofnuclear receptor coactivator 3 (Ncoa3) in pluripotency maintenance. Journal of Biological Chemistry 287 38295-38304. (doi:10.1074/jbc.M112.373092)
83. Xu J, Qiu Y, DeMayo FJ, Tsai SY, Tsai MJ & O’Malley BW 1998 Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science 279 1922-1925. (doi:10.1126/science.279.5358.1922)
84. Xu J, Wu RC & O’Malley BW 2009 Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nature Reviews. Cancer 9 615-630. (doi:10.1038/nrc2695)
85. Yamamoto K & Alberts B 1975 The interaction of estradiol-receptor protein with the genome: an argument for the existence of undetected specific sites. Cell 4 301-310. (doi:10.1016/0092-8674(75)90150-6)
86. Yan F, Yu Y, Chow DC, Palzkill T, Madoux F, Hodder P, Chase P, Griffin PR, O’Malley BW & Lonard DM 2014 Identification of Verrucarin A as a potent and selective steroid receptor coactivator-3 small molecule inhibitor. PLoS ONE 9 e95243. (doi:10.1371/journal.pone.0095243)
87. Yi P, Wu RC, Sandquist J, Wong J, Tsai SY, Tsai MJ, Means AR & O’Malley BW 2005 Peptidyl-prolyl isomerase 1 (Pin1) serves as a coactivator of steroid receptor by regulating the activity of phosphorylated steroid receptor coactivator 3 (SRC-3/AIB1). Molecular and Cellular Biology 25 9687-9699. (doi:10.1128/MCB.25.21.9687-9699.2005)
88. Yi P, Feng Q, Amazit L, Lonard DM, Tsai SY, Tsai MJ & O’Malley BW 2008 Atypical protein kinase C regulates dual pathways for degradation of the oncogenic coactivator SRC-3/AIB1. Molecular Cell 29 465-476. (doi:10.1016/j.molcel.2007.12.030)
89. York B & O’Malley BW 2010 Steroid receptor coactivator (SRC) family: masters of systems biology. Journal of Biological Chemistry 285 38743-38750. (doi:10.1074/jbc.R110.193367)
90. York B, Reineke EL, Sagen JV, Nikolai BC, Zhou S, Louet JF, Chopra AR, Chen X, Reed G, Noebels J et al. 2012 Ablation of steroid receptor coactivator-3 resembles the human CACT metabolic myopathy. Cell Metabolism 15 752-763. (doi:10.1016/j.cmet.2012.03.020)
91. York B, Sagen JV, Tsimelzon A, Louet JF, Chopra AR, Reineke EL, Zhou S, Stevens RD, Wenner BR, Ilkayeva O et al. 2013 Research resource: tissueand pathway-specific metabolomic profiles of the steroid receptor coactivator (SRC) family. Molecular Endocrinology 27 366-380. (doi:10.1210/me.2012-1324)
92. Yu C, York B, Wang S, Feng Q, Xu J & O’Malley BW 2007 An essential function of the SRC-3 coactivator in suppression of cytokine mRNA translation and inflammatory response. Molecular Cell 25 765-778. (doi:10.1016/j.molcel.2007.01.025)
93. Zhao W, Chang C, Cui Y, Zhao X, Yang J, Shen L, Zhou J, Hou Z, Zhang Z, Ye C et al. 2014 Steroid receptor coactivator-3 regulates glucose metabolism in bladder cancer cells through coactivation of hypoxia inducible-factor 1a. Journal of Biological Chemistry 289 11219-11229. (doi:10.1074/jbc.M113.535989)